Biotechnology
Orchid Health’s Whole Genome Sequencing for Embryos: A Breakthrough in Reproductive Autonomy
Orchid Health has commercialized the world's first whole genome sequencing for embryos, allowing for 99% genomic data analysis, a significant improvement over previous methods. This technology enables prospective parents to screen for thousands of monogenic and polygenic diseases, empowering informe…
AI-Driven Autonomous Laboratories: Disrupting Biotech Discovery
The biotechnology industry, particularly drug discovery, has been historically slow and expensive due to manual lab work and high overhead. AI-driven autonomous laboratories are poised to revolutionize this by automating experimental design and execution, drastically reducing costs, and accelerating…
Billion To One: From Prenatal Diagnostics to the Holy Grail of Cancer Detection
Billion To One, a molecular diagnostics company, has commercialized a highly sensitive prenatal genetic test by developing a novel method to reduce noise in DNA amplification. This foundational technology, which involves adding synthetic DNA "spikes" to samples, allows for precise identification of …
Centivax Secures $37M for Universal Flu Vaccine Development
Centivax has raised $37 million to develop a universal influenza vaccine aimed at reducing the global burden of infectious diseases. The initiative represents a strategic move toward broad-spectrum viral protection rather than strain-specific seasonal updates.